Cambiar Investors Boosts Stake in The Cooper Companies

The investment firm acquired over 55,000 shares of the medical device company in the fourth quarter.

Apr. 12, 2026 at 1:37pm

An extreme close-up of precision medical device components and machinery, dramatically lit against a dark background, conceptually representing the technological innovation and manufacturing prowess of a leading global medical device company.Cambiar Investors' substantial stake in The Cooper Companies signals confidence in the medical device maker's ability to drive innovation and growth.San Ramon Today

Cambiar Investors LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 55,577 shares of the medical device company's stock, valued at approximately $4,555,000.

Why it matters

This investment by Cambiar Investors, a respected institutional investor, signals confidence in The Cooper Companies' growth prospects within the medical device industry. The company's contact lens and women's health product lines have performed well, and this additional capital injection could support further expansion and innovation.

The details

Cambiar Investors LLC acquired the 55,577 shares of The Cooper Companies, Inc. during the fourth quarter of 2025. This new position represents a $4.56 million investment in the medical device company. Several other large institutional investors also added to or reduced their stakes in Cooper Companies during the same period.

  • Cambiar Investors LLC acquired the shares in the fourth quarter of 2025.

The players

Cambiar Investors LLC

An investment management firm that focuses on value-oriented strategies across global equity markets.

The Cooper Companies, Inc.

A global medical device company that operates in the vision care and women's health product markets.

Got photos? Submit your photos here. ›

The takeaway

Cambiar Investors' substantial stake in The Cooper Companies signals confidence in the medical device maker's ability to drive innovation and growth in the years ahead.